Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Angler101on Jun 05, 2023 1:37pm
149 Views
Post# 35480759

RE:KOL

RE:KOLHey Venture.....I guess you expected a courier from the FDA to show up this morning at Oncy's head office at 9:00 sharp with an Accelerated Approval certificate, and repesentatives from 5 or 6 Big Pharmas would be fighting all weekend with each other on the front lawn for the rights to Pela?...No?...well, then .if you're so sure thst the share price needs to rise exponentially before they'll ever get a buyout, and you're that impatient and you think this is the "same old story line", and you believe that "they just can't get any traction", and "the prospects of a happy ending are growing even more remote", then instead of whining, I dare you to sell your shares (if you actually own any) and go ahead and short the stock and see how that works out for ya.....GL
<< Previous
Bullboard Posts
Next >>